Filing Details

Accession Number:
0001628280-24-049079
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-25 07:28:56
Reporting Period:
2024-11-22
Accepted Time:
2024-11-25 07:28:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386570 Chromadex Corp. CDXC Medicinal Chemicals & Botanical Products (2833) 262940963
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834681 Ozan Pamir 10900 Wilshire Blvd. Suite 600
Los Angeles CA 90024
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-22 2,907 $7.36 2,907 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average purchase price for the transaction reported was $7.36, and the range of prices were between $7.345 and $7.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.